Cross-Dehydrogenative Coupling Reaction
FULL PAPER
was purified by flash chromatography on alkalescence silica gel to afford
the corresponding products.
129.6, 147.9, 148.7, 148.9 ppm; EIMS: m/z (%): 328 (30) [M+], 268 (100),
104 (15), 77 (36).
1-Nitromethyl-2-phenyl-1,2,3,4-tetrahydroisoquinoline (2a): 1H NMR
(400 MHz, CDCl3): d=2.82 (dt, J=16.4, 4.9 Hz, 1H), 3.06–3.13 (m, 1H),
3.61–3.69 (m, 2H), 4.57 (dd, J=11.9, 6.6 Hz, 1H), 4.89 (dd, J=12.0,
8.0 Hz, 1H), 5.56 (t, J=8.0 Hz, 1H), 6.87 (t, J=7.3 Hz, 1H), 6.99 (d, J=
8.2 Hz, 2H), 7.14 (d, J=7.2 Hz, 1H), 7.18–7.29 ppm (m, 5H); 13C NMR
(100 MHz, CDCl3): d=26.7, 42.3, 58.4, 79.0, 115.3, 119.7, 126.9, 127.2,
128.3, 129.4, 129.7, 133.2, 135.5, 148.6 ppm; EIMS: m/z (%): 268 (43)
[M+], 208 (100), 77 (5).
1-Nitromethyl-2-p-tolyl-1,2,3,4-tetrahydroisoquinoline (2b): 1H NMR
(400 MHz, CDCl3): d=2.25 (s, 3H), 2.73 (dt, J=16.0, 4.0 Hz, 1H), 3.01–
3.05 (m, 1H), 3.53–3.60 (m, 2H), 4.54 (dd, J=12.0, 6.4 Hz, 1H), 4.83 (dd,
J=12.0 Hz, 8.0 Hz, 1H), 5.48 (t, J=8.0 Hz, 1H), 6.88 (d, J=8.6 Hz, 2H),
7.06 (d, J=8.6 Hz, 2H), 7.11–7.25 ppm (m, 4H); 13C NMR (100 MHz,
CDCl3): d=0.5, 26.4, 42.5, 58.6, 79.0, 116.1, 126.8, 127.2, 128.2, 129.3,
129.5, 130.2, 133.2, 135.6, 146.6 ppm; EIMS: m/z (%): 282 (60) [M+], 222
(100), 118 (64), 91 (66), 77(12).
6,7-Dimethoxy-2-(4-methoxyphenyl)-1-nitromethyl-1,2,3,4-tetrahydroiso-
quinoline (2i): 1H NMR (400 MHz, CDCl3): d=2.57 (dt, J=4.4, 16.0 Hz,
1H), 2.88–2.96 (m, 1H), 3.51–3.57 (m, 1H), 3.75 (s, 3H), 3.86 (s, 6H),
4.56 (dd, J=5.7, 12.0 Hz, 1H), 4.81 (dd, J=8.0, 12.0 Hz, 1H), 5.29 (dd,
J=5.7 Hz, 8.6 Hz, 1H), 6.60 (s, 1H), 6.62 (s, 1H), 6.81 (d, J=8.0 Hz,
2H), 6.91 ppm (d, J=8.0 Hz, 2H); 13C NMR(100 MHz, CDCl3): d=25.3,
43.4, 55.7, 56.0, 56.2, 58.9, 79.1, 109.6, 112.0, 114.8, 119.4, 124.6, 127.7,
143.3, 147.9, 148.9, 154.2 ppm; EIMS: m/z (%): 358 (78) [M+], 298 (92),
296 (100), 282 (80), 254 (39), 149 (42), 77 (8).
1-(1-Nitroethyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (2j): 1H NMR
(400 MHz, CDCl3): d=[1.53 (d, J=8.0 Hz), 1.69 (d, J=8.0 Hz), 3H],
[2.83–2.94 (m), 2.99–3.09 (m), 2H], [3.51–3.61 (m), 3.80–3.86 (m), 2H],
[4.84–4.92 (m), 5.01–5.08 (m), 1H], 5.22–5.26 (m, 1H), 6.79–6.84 (m,
1H), 6.97–7.01 (m, 2H), 7.08–7.29 (m, 6H) ppm; 13C NMR (100 MHz,
CDCl3): d=(16.4, 17.4), (26.4, 26.7), (42.7, 43.5), (61.1, 62.7), (85.4, 88.9),
(114.5, 115.4), (118.8, 119.3), 126.1, 126.6, 127.2, 128.2, 128.3, 128.7, 129.1,
129.3, 129.4, 129.6, 132.0, 133.8, 134.8, 135.6, 148.9, 49.2 ppm; EIMS: m/z
(%): 282 (17) [M+], 208 (100), 104 (46), 77 (55).
1-(1-Nitroethyl)-2-p-tolyl-1,2,3,4-tetrahydroisoquinoline (2k): 1H NMR
(400 MHz, CDCl3): d=[1.52 (d, J=6.8 Hz), 1.68 (d, J=6.8 Hz), 3H],
[2.23 (s), 2.26 (s), 3H], [2.76–2.91 (m), 2.95–3.08 (m), 2H], [3.48–3.59
(m), 3.76–3.83 (m), 2H], [4.87 (dq, J=6.8, 13.6 Hz), 5.03 (dq, J=6.6,
13.3 Hz), 1H], 5.11–5.22 (m, 1H), 6.83–6.95 (m, 2H), 6.99–7.27 ppm (m,
6H); 13C NMR (100 MHz, CDCl3): d=(16.4, 17.3), 20.3, (26.2, 26.5),
(43.0, 43.9), (61.4, 62.9), (85.5, 88.9), (115.1, 116.0), 126.0, 126.5, 127.2,
128.1, 128.3, 128.8, 128.9, 129.1, 129.8, 129.9, 132.0, 133.8, 134.8, 135.7,
146.8, 147.1 ppm; EIMS: m/z (%): 296 (14) [M+], 222 (100), 149 (38), 91
(31), 77 (10).
2-(4-Methoxyphenyl)-1-nitromethyl-1,2,3,4-tetrahydroisoquinoline (2c):
1H NMR (400 MHz, CDCl3) d=2.69 (dt, J=16.0, 4.0 Hz, 1H), 2.96–3.02
(m, 1H), 3.50–3.56 (m, 2H), 3.74 (s, 3H), 4.55 (dd, J=12, 5.8 Hz, 1H),
4.81 (dd, J=12, 8.6 Hz, 1H), 5.38 (dd, J=5.8, 8.6 Hz, 1H), 6.81 (d, J=
9.0 Hz, 2H), 6.91 (d, J=9.0 Hz, 2H), 7.09–7.33 ppm (m, 4H); 13C NMR
(100 MHz, CDCl3): d=25.8, 43.1, 55.5, 58.9, 78.9, 114.7, 118.8, 126.6,
126.9, 127.9, 129.4, 132.9, 135.4, 143.0, 153.9 ppm; EIMS: m/z (%): 298
(73) [M+], 239 (100), 223 (55), 115 (50), 91(12), 77 (18).
2-(2-Methoxyphenyl)-1-nitromethyl-1,2,3,4-tetrahydroisoquinoline (2d):
1H NMR (400 MHz, CDCl3) d=2.71 (ddd, J=2.4, 3.8 Hz, 16.5 Hz, 1H),
2.94–2.98 (m, 1H), 3.44–3.61 (m, 2H), 3.82 (s, 3H), 4.53 (dd, J=5.2,
12.0 Hz, 1H), 4.82 (dd, J=8.0, 12.0 Hz, 1H), 5.50 (dd, J=8.3, 5.1 Hz,
1H), 6.81–6.88 (m, 3H), 6.98–7.05 (m, 1H), 7.12–7.30 ppm (m, 4H);
13C NMR (100 MHz, CDCl3): d=27.1, 43.2, 56.0, 58.4, 79.4, 112.8, 121.3,
122.2, 124.3, 126.6, 129.7, 133.9, 135.6, 139.2, 153.4 ppm; EIMS: m/z (%):
298 (62) [M+], 239 (95), 222 (100), 115 (33), 91(11), 77 (21).
2-(4-Bromophenyl)-1-(1-nitroethyl)-1,2,3,4-tetrahydroisoquinoline (2l):
1H NMR (400 MHz, CDCl3): d=[1.55 (d, J=8.0 Hz), 1.67 (d, J=8.0 Hz),
3H], [2.85–2.96 (m), 3.01–3.08 (m), 2H], [3.45–3.60 (m), 3.78–3.84 (m),
2H], [4.83–4.90 (m), 4.97–5.04 (m), 1H], 5.13–5.21 (m, 1H), 6.82–6.87
(m, 2H), 7.10–7.37 ppm (m, 6H); 13C NMR (100 MHz, CDCl3): d=(16.8,
17.5), (26.4, 26.9), (43.0, 43.9), (61.3, 62.9), (85.6, 89.0), (116.3, 117.2),
126.5, 127.0, 127.2, 127.4, 128.5, 128.6, 128.9, 129.4, 129.6, 132.0, 132.2,
132.3, 132.7, 133.7, 134.7, 135.5, 148.1, 148.4 ppm; EIMS: m/z (%): 362
(8), 360 (8) [M+], 314 (24), 312 (20), 288 (100), 206 (26), 129 (54), 115
(43), 91 (10), 77 (14).
1-(1-Nitropropyl)-2-phenyl-1,2,3,4-tetrahydroisoquinoline (2m): 1H NMR
(400 MHz, CDCl3): d=0.91–0.96 (m, 3H), [1.77–1.89 (m), 2.04–2.16 (m),
2H], [2.83–2.93 (m), 3.02–3.11 (m) 2H], [3.48–3.69 (m), 3.81–3.88 (m),
2H], [4.64–4.70 (m), 4.83–4.89 (m), 1H], [5.12 (d, J=9.5 Hz), 5.23 (d, J=
9.5 Hz), 1H], 6.76–6.83 (m, 1H), 6.92–7.00 (m, 2H), 7.13–7.29 ppm (m,
6H); 13C NMR (100 MHz, CDCl3): d=10.7, (24.6, 25.0), (25.7, 26.8),
(42.3, 43.5), (60.7, 62.2), (93.0, 96.1), (114.1, 115.8), (118.6, 119.4), 125.9,
126.6, 127.2, 128.2, 128.6, 128.7, 129.2, 129.3, 129.4, 132.6, 133.9, 134.7,
135.5, 149.0, 149.1 ppm; EIMS: m/z (%): 296 (36) [M+], 209 (100), 115
(78), 104 (82), 77 (81).
1-(1-Nitropropyl)-2-p-tolyl-1,2,3,4-tetrahydroisoquinoline (2n): 1H NMR
(400 MHz, CDCl3): d=0.91–0.95 (m, 3H), [1.77–1.87 (m), 2.01–2.19 (m),
2H], 2.12 (s, 3H), [2.78–2.89 (m), 2.99–3.08 (m), 2H], [3.46–3.64 (m),
3.78–3.86 (m), 2H], [4.63–4.69 (m), 4.81–4.87 (m), 1H], [5.04 (d, J=
12.0 Hz), 5.15 (d, J=12.0 Hz), 1H], 6.81–6.89 (m, 2H), 6.97–7.25 ppm
(m, 6H); 13C NMR (100 MHz, CDCl3): d=10.7, (20.2, 20.3), (24.6, 25.0),
(25.5, 26.6), (42.5, 43.8), (60.9, 62.3), (93.1, 96.2), (114.7, 116.4), 125.8,
126.5, 127.2, 128.1, 128.6, 128.7, 128.9, 129.4, 129.7, 129.9, 132.5, 133.9,
134.7, 135.6, 146.9 ppm; EIMS: m/z (%): 310 (32) [M+], 223 (100), 207
(34), 118 (57), 115 (52), 91 (84), 77 (12); HRMS (EI): m/z calcd for
C19H22N2O2: 310.1681; found: 310.1684.
2-(4-Fluorophenyl)-1-nitromethyl-1,2,3,4-tetrahydroisoquinoline
(2e):
1H NMR (400 MHz, CDCl3) d=2.71 (dt, J=16.0, 4.4 Hz, 1H), 2.98–3.04
(m, 1H), 3.59 (dd, J=9.1, 4.4 Hz, 2H), 4.56 (dd, J=12.0, 5.8 Hz, 1H),
4.83 (dd, J=12.0, 8.6 Hz, 1H), 5.42 (dd, J=8.6, 5.8 Hz, 1H), 6.88–6.92
(m, 4H), 7.12–7.27 ppm (m, 4H); 13C NMR (100 MHz, CDCl3): d=25.7,
29.7, 42.8, 58.7, 78.8, 115.8 (d,
7.4 Hz), 126.7, 126.9, 128.1, 129.4, 132.5, 135.2, 145.3, 157.1 ppm (d, J-
ACHTUNGTRENNUNG
(C,F)=239.2 Hz); EIMS: m/z (%): 286 (63) [M+], 227 (100), 115 (70), 95
JACTHUNGTRENNU(G C,F)=22.2 Hz), 117.9 (d, JACHTUGNTREN(NUNG C,F)=
(58), 91 (12), 77 (8); HRMS (EI): m/z calcd for C16H15FN2O2: 286.1118;
found: 286.1117.
2-(4-Chlorophenyl)-1-nitromethyl-1,2,3,4-tetrahydroisoquinoline
(2 f):
1H NMR (400 MHz, CDCl3): d=2.76 (dt, J=4.4, 16.0 Hz, 1H), 3.05
(ddd, J=15.1, 8.4, 6.3 Hz, 1H), 3.46–3.73 (m, 2H), 4.55 (dd, J=6.3,
12.0 Hz, 1H), 4.82 (dd, J=8.0, 12.0 Hz, 1H), 5.47 (t, J=8.0 Hz, 1H), 6.88
(d, J=9.1 Hz, 2H), 7.10–7.26 ppm (m, 6H); 13C NMR (100 MHz,
CDCl3): d=26.3, 42.4, 58.4, 78.8, 116.7, 124.6, 127.0, 127.2, 128.4, 129.5,
132.7, 135.3, 147.3 ppm; EIMS: m/z (%): 302 (94) [M+], 244 (100), 149
(64), 115 (72), 111 (50), 77 (14).
2-(4-Bromophenyl)-1-nitromethyl-1,2,3,4-tetrahydroisoquinoline
(2g):
1H NMR (400 MHz, CDCl3) d=2.79 (dt, J=4.8, 16.0 Hz, 1H), 3.01–3.15
(m, 1H), 3.57–3.65 (m, 1H), 4.57 (dd, J=6.4, 12.0 Hz, 1H), 4.82 (dd, J=
8.0, 12.0 Hz, 1H), 5.47 (t, J=8.0 Hz, 1H), 6.84 (d, J=9.1 Hz, 2H), 7.16–
7.31 (m, 4H), 7.34 ppm (d, J=9.1 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d=26.1, 42.0, 58.1, 78.6, 111.5, 116.7, 126.8, 126.9, 128.2, 129.2, 132.2,
132.4, 135.0, 147.5 ppm; EIMS: m/z (%): 348 (62), 346 (65) [M+], 288
(100), 118 (99), 90 (25), 77 (12).
6,7-Dimethoxy-1-nitromethyl-2-phenyl-1,2,3,4-tetrahydroisoquinoline
(2h): 1H NMR (400 MHz, CDCl3): d=2.68 (dt, J=4.4, 16.0 Hz, 1H),
2.96–3.04 (m, 1H), 3.54–3.61 (m, 1H), 3.65–3.70 (m, 1H), 3.85 (s, 6H),
4.56 (dd, J=6.4, 12.0 Hz, 1H), 4.85 (dd, J=8.0, 12.0 Hz, 1H), 5.46 (t, J=
8.0 Hz, 1H), 6.60 (s, 1H), 6.65 (s, 1H), 6.85 (t, J=8.0 Hz, 1H), 6.87 (d,
J=8.0 Hz, 2H), 7.24–7.28 ppm (m, 2H); 13C NMR (100 MHz, CDCl3):
d=25.9, 42.2, 56.0, 56.2, 58.1, 78.9, 109.8, 111.9, 115.7, 119.7, 124.7, 127.6,
2-(4-Bromophenyl)-1-(1-nitropropyl)-1,2,3,4-tetrahydroisoquinoline (2o):
1H NMR (400 MHz, CDCl3) d=0.91–0.96 (m, 3H), [1.73–1.84 (m), 1.95–
2.21 (m), 2H], [2.83–2.95 (m), 2.98–3.10 (m), 2H], [3.41–3.48 (m), 3.76–
3.86 (m), 1H], [3.53–3.62 (m), 1H], [4.62–4.68 (m), 4.79–4.85 (m), 1H],
[5.05 (d, J=12.0 Hz), 5.17 (d, J=12.0 Hz), 1H], [6.80 (d, J=9.1 Hz), 6.84
(d, J=9.1 Hz), 2H], 7.14–7.30 ppm (m, 6H); 13C NMR (100 MHz,
CDCl3): d=10.8, (24.9, 25.1), (25.8, 26.9), (42.6, 43.9), (60.8, 62.3), (93.1,
Chem. Eur. J. 2012, 18, 620 – 627
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
625